Company of the Year | 合法醫療器材資訊網

2020年12月9日—9,2020.MariaRachal'sheadshot.MariaRachalEditor.CourtesyofAbbott.FouryearsagoAbbottsoughttogetoutofitsacquisitionof ...

Four years ago Abbott sought to get out of[1] its acquisition of point-of-care diagnostics manufacturer Alere amid billing concerns and a recall. The deal ultimately went through in 2017 for $5.3 billion as one of the last big M&A plays under CEO of 21 years Miles White.

Fast forward a few years and massive demand for coronavirus testing prompted Abbott to, in a matter of months, more than double the U.S. footprint of the portable diagnostic machines descendent from Alere and typically used to test for infections like strep and flu in doctors offices.

Speaking to investors in October, newly minted CEO Robert Ford called the recent testing expansion "the execution of that Alere strategy, which is to build a whole new testing platform outside of the walls of a lab," adding, "COVID has actually given us an opportunity to accelerate that strategy."

Andrea Wainer, h...